Purpose
|
Severe hypertensive disorders of pregnancy are associated with high rates of maternal and fetal morbidity and mortality.
|
It is imperative in this clinical situation that severe blood pressure in pregnancy is treated. This guideline provides information about the use and administration of oral Nifedipine, intravenous labetalol and when labetalol is contraindicated, the use and administration of intravenous hydralazine.
|
Guideline
|
To download the complete guideline select the following link
|
|
|
|
|
Published: 24 January 2012
|
|  | |
|
|
Royal Women's Hospital Clinical Practice Guidelines (CPGs) are intended to provide guidance to health care professionals, based on a thorough evaluation of research evidence, on the practical assessment and management of specific clinical issues or situations. The guidelines allow some flexibility on the part of the health care professional based on the needs of the specific patient for whom they are caring.
|
Please remember to read our disclaimer.
|
